NEW YORK (AP) â¿¿ Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and Nasdaq Stock Market: NYSE: Best Buy Co., down $2.49 at $38.56 The company's profit edged up 1 percent but fell far short of what analysts were expecting as shoppers spent less. Gamestop Corp., down $1.17 at $20.71 Best Buy Co. said it would start a trade-in program for used games this summer, entering the niche market. Callaway Golf Co., down 63 cents at $6.97 The golf company said it anticipates second-quarter results well below expectations on the slow economic recovery. Patriot Coal Corp., down 37 cents at $16.51 The company said second-quarter results will be hurt on suspended production at a West Virginia mine where a major roof collapsed. NASDAQ: Netflix Inc., down $3.31 at $123.50 An analyst downgraded the stock to "Hold" from "Buy," citing potential competition from Hulu.com. Dell Inc., up 91 cents at $14 Dell said it's working closely with OnLive Inc., a pioneer of on-demand instant play video games, to power its game service. Smart Balance Inc., down $1.24 at $3.91 The maker of butter-like spreads and other foods slashed its sales outlook on a weak economy and competitive pressure. Amylin Pharmaceuticals Inc., down 48 cents at $17.31 Amylins diabetes drug Bydureon topped rival Januvia in a study, but results showed it was on par with several other drugs.
More from Stocks
Top 5 Stock Winners in Dow Jones Industrial Average This Week
The Dow Jones Industrial Average finished Friday above 28000 for the first time ever. Here are the top 5 winning stocks in the Dow from this week.
Bottom 3 Loser Stocks in Dow Jones Industrial Average This Week
These 3 stocks did not help the Dow Jones Industrial Average finish Friday above 28000. Here are the bottom 3 losing stocks from this week.
Why Stock Charts Are a More Valuable Tool Than Ever
What I have found is that the real value of charts is as a trade management tool.
Novartis Still a Buy Despite Controversy Over Blockbuster Drug
Despite the issues that have bubbled up related to its breakthrough drug for spinal muscular atrophy, Zolgensma, Novartis "has the newest pipeline with many drugs just beginning to have an impact on the company's bottom line," Cramer told members of his Action Alerts PLUS club for investors during an exclusive video-conference call.